Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.1K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

451
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
451
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

269
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
269
The Anchoring-and-Adjustment Heuristic01:25

The Anchoring-and-Adjustment Heuristic

7.8K
In order to make good decisions, we use our knowledge and our reasoning. Often, this knowledge and reasoning is sound and solid. However, sometimes, we are swayed by biases or by others manipulating a situation. For example, let’s say you and three friends wanted to rent a house and had a combined target budget of $1,600. The realtor shows you only very run-down houses for $1,600 and then shows you a very nice house for $2,000. Might you ask each person to pay more in rent to get the...
7.8K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

373
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
373
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

693
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
693

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complex mitral annular calcification: why surgical access still matters.

Journal of visualized surgery·2026
Same author

Machine Learning Models for Objective Assessment of Vascular Anastomoses Using Computational Fluid Dynamics for Surgical Skill Training-A Retrospective Study.

Journal of clinical medicine·2026
Same author

The Legacy of the First Valve: Outcomes of Redo Surgical Aortic Valve Replacement After Prior Transcatheter Versus Prior Surgical Aortic Valve Replacement-A Narrative Review.

Journal of clinical medicine·2026
Same author

Right Anterior Thoracotomy Versus Partial Sternotomy for Isolated Aortic Valve Replacement: A Propensity Analysis of Clinical Outcomes and Hospital Costs.

Medicina (Kaunas, Lithuania)·2026
Same author

Longer-Term Follow-up of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in Low Risk Patients: What Does the Data Tell Us?

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same author

Artificial Intelligence-Driven Hypertension Management: Implications for Quality Improvement and Prevention of End-Organ Damage.

Life (Basel, Switzerland)·2026

Related Experiment Video

Updated: Feb 4, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

10.0K

Risk-Adjusted Outcomes After Minimally Invasive Direct Coronary Artery Bypass Grafting: A Multicentre Experience.

Samuel Heuts1,2,3, Massimo Baudo4, Wouter Oosterlinck1

  • 1Department of Cardiac Surgery, University Hospitals Leuven, Leuven, 3000, Belgium.

European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|February 3, 2026
PubMed
Summary
This summary is machine-generated.

Minimally invasive direct coronary artery bypass grafting (MIDCAB) shows excellent safety and reproducibility for left anterior descending artery (LAD) disease treatment. Risk-adjusted mortality rates were consistently low, supporting its widespread adoption in cardiac surgery.

Keywords:
CUSUMcoronary artery bypass graftinglearning-curveminimally invasive direct coronary artery bypass graftingmortalityrisk-adjusted mortality

More Related Videos

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.3K
Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
12:00

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model

Published on: November 24, 2014

15.9K

Related Experiment Videos

Last Updated: Feb 4, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

10.0K
Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.3K
Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
12:00

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model

Published on: November 24, 2014

15.9K

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Cardiac Surgery
  • Coronary Artery Bypass Grafting

Background:

  • Minimally invasive direct coronary artery bypass grafting (MIDCAB) offers an alternative to conventional coronary artery bypass grafting (CABG).
  • The treatment of left anterior descending artery (LAD) disease is a key indication for MIDCAB.
  • Evaluating risk-adjusted mortality is crucial for assessing the safety of surgical procedures.

Purpose of the Study:

  • To evaluate the risk-adjusted mortality rates associated with MIDCAB procedures.
  • To compare observed versus expected mortality using the EuroSCORE II.
  • To assess the safety and reproducibility of both robotic and non-robotic MIDCAB techniques.

Main Methods:

  • A multicenter study included 1231 patients undergoing isolated MIDCAB.
  • The European System for Cardiac Operative Risk Evaluation (EuroSCORE II) was used to calculate predicted 30-day mortality.
  • Observed-to-expected (O-E) mortality ratios were analyzed, stratified by risk and procedure type (robotic vs. non-robotic).
  • Cumulative sum (CUSUM) analyses assessed institutional learning curves.

Main Results:

  • The overall mortality rate was 0.8%, with a risk-adjusted O-E ratio of 0.50.
  • Robotic MIDCAB had an O-E ratio of 0.37, while non-robotic MIDCAB had an O-E ratio of 0.79.
  • No significant interaction between risk categories and procedure type was observed.
  • CUSUM analyses indicated a safe learning curve with consistently low O-E ratios (<1).

Conclusions:

  • Both robotic and non-robotic MIDCAB procedures demonstrate excellent, low risk-adjusted mortality rates.
  • The observed-to-expected mortality ratios were consistently below 1, confirming safety.
  • Findings support the safety, reproducibility, and potential for widespread adoption of MIDCAB for LAD disease.